You are here

  • Home
  • Archive
  • Volume 11, Issue 3
  • Pre-existing TGF-β-specific T-cell immunity in patients with pancreatic cancer predicts survival after checkpoint inhibitors combined with radiotherapy

Citation Tools

Article menu
Basic tumor immunology
Original research
Pre-existing TGF-β-specific T-cell immunity in patients with pancreatic cancer predicts survival after checkpoint inhibitors combined with radiotherapy

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Mortensen REJ, Holmström MO, Lisle TL, et al
Pre-existing TGF-β-specific T-cell immunity in patients with pancreatic cancer predicts survival after checkpoint inhibitors combined with radiotherapy
Journal for ImmunoTherapy of Cancer 2023;11:e006432. doi: 10.1136/jitc-2022-006432